Advanced Reconstructive Surgery Alliance Launches Platform

Center for Restorative Breast Surgery and St. Charles Surgical Hospital Join The Plastic Surgery Center & Affiliates in Elite Network of Reconstructive and Cosmetic Surgeons

Advanced Reconstructive Surgery Alliance (“ARSA”), a comprehensive physician management services organization, officially announced its formation, as well as its partnership with Center for Restorative Breast Surgery and St. Charles Surgical Hospital.  Center for Restorative Breast Surgery (“CRBS”) and St. Charles Surgical Hospital joins the ARSA consortium, which is comprised of The Plastic Surgery Center, Institute for Advanced Reconstruction, Premier Surgical Network, Look Natural Hair Restoration and Sycamore Medispa

These best-in-class practices represent many of the leading reconstructive and cosmetic surgeons throughout the United States.  

Headquartered in Tinton Falls, NJ, ARSA is partnering with leading reconstructive and cosmetic surgeons who seek a strategic partner with the capital resources and expertise to invest in best-in-class practice infrastructure and facilitate future growth. As part of this alliance, ARSA practice members will continue to deliver excellent patient care and further enhance clinical quality through collaboration with their new colleagues and ARSA’s management resources. Joining ARSA will offer members greater economies of scale, enhanced clinical interaction, and an overall competitive advantage. 

“This is an exciting time for the Advanced Reconstructive Surgery Alliance, and we are proud to be partnering with the organization,” said Frank DellaCroce, MD, FACS, Co-Founder of the Center for Restorative Breast Surgery.  “We are committed to delivering the highest quality care that aligns with ARSA.  This alliance should allow us to expand our presence within the markets we serve, positively impacting the lives of more patients.” 

Center for Restorative Breast Surgery’s physicians are pioneers in the art of rebuilding breasts lost to cancer, preventive mastectomy, developmental defects, and deformities associated with previous surgery. CRBS utilizes sophisticated microsurgical techniques allowing for recreation of the breast with natural tissue while preserving strength and restoring beauty.  CRBS has pioneered groundbreaking procedures including Nipple Sparing Mastectomy, the Stacked Flap SM, the SGAP, the BODY LIFT Flap®, and the APEX FlapSM. 

ARSA is bringing together national leaders in reconstructive and cosmetic care.  This network has the common goal of improving life through surgery and science.  The ARSA leadership team is led by Dr. Andrew Elkwood, CEO a practicing reconstructive surgeon.  

“What makes ARSA unique is its focus on reconstructive and cosmetic surgery.  We designed this network with the common goal of bringing together key opinion leaders in the plastic surgery field to provide the best possible care to patients,” explained Andrew Elkwood, MD, CEO of ARSA.  “ARSA has created a business model that enables reconstructive and cosmetic surgeons to have an ownership interest and the ability to participate in ARSA’s future. Practices within the network will continue to drive all clinical decisions and remain highly involved in strategic operations via the Medical Leadership Board.” 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”